Drugs and trials: lessons from Plato. - Wikidata - wikimedia - TriplyDB

Drugs and trials: lessons from Plato.

Drugs and trials: lessons from Plato.

http://www.wikidata.org/entity/Q37174765

about

Drugs and trials: lessons from Plato.

http://www.wikidata.org/entity/Q37174765

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drugs and trials: lessons from Plato.

@en

Drugs and trials: lessons from Plato.

@nl

type

label

Drugs and trials: lessons from Plato.

@en

Drugs and trials: lessons from Plato.

@nl

prefLabel

Drugs and trials: lessons from Plato.

@en

Drugs and trials: lessons from Plato.

@nl

P1433

Q37174765-F9FA7852-558A-4B1F-8979-106FB3E9F030

P1476

Q37174765-47EC13B8-0F28-4CC5-97AB-5EFD451F2197

P2093

Q37174765-A4C56896-B7D7-46F3-A29E-00772529480A

P2860

Q37174765-05BA5736-3DFA-4C18-B328-7F23435D7F64

Q37174765-17D51BF5-C9F4-47C3-BD79-260B2F52C124

Q37174765-359CDB7D-DB3E-494D-8FE4-F9D03EA1EC51

Q37174765-3AE16026-11A8-42C0-957D-7C3670C7CAD1

Q37174765-62213506-ABA6-48F1-9BBD-4BECE4AC28A5

Q37174765-77C1CF2A-6209-4400-98D2-C7B3C237A771

Q37174765-7E04A512-F82A-405E-ABD3-E87C8DAB9E1D

Q37174765-84960CD0-AA5D-4867-BFE9-61CB664F32ED

Q37174765-BA5C1321-E3DB-4476-96BF-5CD8E64E028B

Q37174765-D2F38E92-6AA1-40E9-B812-04405C96D1D2

P304

Q37174765-8220EACF-517C-41C1-A3B5-9FAD358E40C0

P31

Q37174765-295A62CE-2F39-4C39-8616-3065199C3A92

P356

Q37174765-FC0A73B4-DDB2-465D-98F2-9A340BA21270

P433

Q37174765-72718138-683C-4F48-8979-0EF6FB470D58

P478

Q37174765-F4E58BB0-B4FF-4CF4-91E9-BE3BC7AD8631

P577

Q37174765-7FC0D231-5A27-486A-82A2-0E9D91896F58

P698

Q37174765-2644E606-FBE8-471E-8BAD-E49CD923E66E

P932

Q37174765-4BC48667-B832-45A9-8FB5-025A8C27023C

P356

J.CLINTHERA.2013.03.018

P1433

Clinical Therapeutics

P1476

Drugs and trials: lessons from Plato.

@en

P2093

Howard Trachtman

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

Ethical considerations in studying drug safety--the Institute of Medicine report.

The number, quality, and coverage of randomized controlled trials in nephrology.

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration.

P304

688-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLINTHERA.2013.03.018

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23587607

http://www.w3.org/2001/XMLSchema#string

P932

3774268

http://www.w3.org/2001/XMLSchema#string